13D/13G Filings - GENETIC TECHNOLOGIES LTD (GENE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
2:14 pm
Unchanged
2023-12-31 13G Genetic Technologies Limited
GENE
CVI Investments, Inc. 0
0.000%
0
(Unchanged)
Filing
History
2023-02-13
10:20 am
Purchase
2023-02-03 13G Genetic Technologies Limited
GENE
CVI Investments, Inc. 25,097,550
5.400%
25,097,550increase
(New Position)
Filing
History
2020-06-04
4:11 pm
Sale
2020-05-26 13G Genetic Technologies Limited
GENE
Mitchell P. Kopin 3,344,561
1.100%
-4,250,499decrease
(-55.96%)
Filing
History
2020-04-28
4:44 pm
Purchase
2020-04-19 13G Genetic Technologies Limited
GENE
Mitchell P. Kopin 7,595,060
3.600%
7,595,060increase
(New Position)
Filing
History